Patients with ID receiving TNF inhibitors are at greater risk for cutaneous malignancy than patients who are biologic-naïve.

Major and minor relapses are relatively common in GCA and primarily occur within the first 2 years of diagnosis.

Nervous system involvement was common among a cohort of patients with AAV, with these individuals showing less severe renal impairment.

A novel form of upper- and lower-body exercise, blood flow-restricted resistance training (BFR-RT), improves outcomes with rheumatoid arthritis (RA).

Individuals with ulcerative colitis have an increased risk for certain types of cancer based on age, instead of treatment type.

Adolescent vaping of delta-9-tetrahydrocannabinol, cannabidiol, and synthetic cannabinoids increased significantly from 2021 to 2023.

A government-backed meal delivery service for people on Medicaid and Medicare is getting national attention — but not all of it is positive.

There was an increase in disorders of gut-brain interaction (DGBI) during the COVID-19 pandemic for those living in the United States.

We interviewed experts in the field of pediatric rheumatology to understand gaps in juvenile idiopathic arthritis management.

“While the phase 3 results of GCAptAIN did not replicate the positive outcomes observed in the phase 2 trial, we remain committed to continuing to drive scientific progress and deepening the ...

Upadacitinib demonstrated greater clinical efficacy and a comparable safety profile to adalimumab for treating RA, regardless of patients’ baseline CV risks.

The FDA has approved Benlysta for SC administration using an autoinjector in patients 5 years of age and older with active LN.